Article (Published version) (108 Kb) - 
Limited access to UNIGEOther version: https://www.revmed.ch/RMS/2018/RMS-N-601/Place-de-l-immunotherapie-dans-l-asthme-allergique
Highlights
Professional Article
unige:126826 
 |
Place de l'immunothérapie dans l'asthme allergique |
|
| Authors | ||
| Published in | Revue médicale suisse. 2018, vol. 14, no. 601, p. 731-734 | |
| Abstract | Desensitization for pneumallergens is used in daily practice for the treatment of allergic rhinitis and allergic asthma. However, specific immunotherapy has long been debated in the medical literature as a treatment for allergic asthma until the latest international recommendations for the management of asthma (GINA) reveal specific immunotherapy as a treatment in sensitized patients, poorly controlled by inhaled corticosteroids (FEV 1 > 70%). In this article you will find a current overview of the medical literature on the usefulness of specific desensitization to reduce asthma symptoms and symptomatic treatments, prevent the onset of asthma in patients with allergic rhinitis as well as prevent new sensitizations. | |
| Identifiers | PMID: 29620295 | |
| Full text |
Article (Published version) (108 Kb) - Limited access to UNIGE Other version: https://www.revmed.ch/RMS/2018/RMS-N-601/Place-de-l-immunotherapie-dans-l-asthme-allergique |
|
| Structures | ||
| Citation (ISO format) | MARCHAL, Ophélie, ALLALI, Danièle. Place de l'immunothérapie dans l'asthme allergique. In: Revue médicale suisse, 2018, vol. 14, n° 601, p. 731-734. https://archive-ouverte.unige.ch/unige:126826 |
184 hits 
1 download 
Contact an author
Update